• PIH3 Use of Mixed Treatment Comparison Methods in Estimating Efficacy of Treatments for Heavy Menstrual Bleeding

    Jun 1, 2012, 00:00

  • PHP92 Applying Actuarial Methodology to Hosptial Data for Estimation of Medical Errors

    Jun 1, 2012, 00:00

  • PMH70 Medication Adherence and Persistence in Patients Treated with Duloxetine

    Jun 1, 2012, 00:00

  • PGI17 Societal Burden in Patients with Liver Transplantation- The Come Study Results

    Jun 1, 2012, 00:00

  • PR4 Breast Cancer Mortality Rates by Geographic Region, Years of Potential Life Lost, and Value of Productivity Losses among Women Aged 20-49 Years in the United States, 1970–2008

    Jun 1, 2012, 00:00

  • PDB87 Real-World Retrospective Analysis of Demographic Characteristics and Prevalence of Diabetes in Shanghai Minhang District

    Jun 1, 2012, 00:00

  • PCV81 Impact of the Awareness of Cardiovascular Disease (CVD) Risk on the Management in Hypertensive Patient in Korea

    Jun 1, 2012, 00:00

  • PMH35 Cost-Effectiveness of Agomelatine in Treatment of Major Depressive Disorders in Turkey

    Jun 1, 2012, 00:00

  • PHP60 Outcomes of Integrated Medical Care Service Provided in Outpatient Units in a Medical Center- Two-Year Experience

    Jun 1, 2012, 00:00

  • PRS17 Direct Incremental Costs of Chronic Obstructive Pulmonary Disease (Copd) and Asthma in the United States

    Jun 1, 2012, 00:00

  • PCV99 Vip Brazil - Profile of Patients and Resource Use Associated with Total Hip or Knee Replacement Surgery in the Public Health Care System in Brazil

    Jun 1, 2012, 00:00

  • SB2 Comparative Effectiveness of On-Pump and Off-Pump Coronary Artery Bypass Grafting Among Elderly Patients – a Retrospective Analysis of Medicare Claims Data

    Jun 1, 2012, 00:00

  • PUK26 Examining Knowledge and Information Seeking Behaviors Towards Blood Transfusion among Individuals with Chronic Kidney Disease

    Jun 1, 2012, 00:00

  • PCV19 Venous Thromboembolism Prophylaxis and Clinical Consequences in Hospitalized Medically Ill Patients

    Jun 1, 2012, 00:00

  • PMH17 Obesity and Risk of Depression/Anxiety in Children and Adolescents- A Medical Expenditure Panel Survey Study

    Jun 1, 2012, 00:00

  • PCN34 Descriptive Costs of Chemotherapy Treatment for Stage 3 and Stage 4 Colon Cancer

    Jun 1, 2012, 00:00

  • PDB101 Diaps 79- Estimated Hospitalizations Attributable to Diabetes Mellitus in Brazilian Public Health Care System (SUS) Between 2008-2010

    Jun 1, 2012, 00:00

  • PCV108 Measuring the Impact of Tobacco Control Policies on Health Outcomes Using the TOSCA (Tobacco Policy Outcomes and Smoking Cessation) Model

    Jun 1, 2012, 00:00

  • PSS21 Assessing Pruritus Among Patients with Atopic Dermatitis- Targeted Literature and Instrument Review

    Jun 1, 2012, 00:00

  • PND53 Discrepancies in Hospitalization Trends by Epilepsy Among Three Latin America Countries

    Jun 1, 2012, 00:00

  • PIN5 Systematic Review of Interferon Free Based Regimens for Chronic Hepatitis C Treatment

    Jun 1, 2012, 00:00

  • PRM29 Comparison of Discrete Discounting and Non-Constant Exponential Discounting Approaches to Calcuate Future Gains in Quality-Adjusted Life-Years

    Jun 1, 2012, 00:00

  • PDB68 Adherence to Oral Antidiabetic Medications in the Pediatric Population With Type 2 Diabetes

    Jun 1, 2012, 00:00

  • PCV67 Pharmacy Cost Sharing, Antiplatelet Therapy Utilization, and Health Outcomes for Patients with Acute Coroncary Syndrome

    Jun 1, 2012, 00:00

  • PHP89 Korean Recommendations on Health Economic Evaluation (2nd and Updated Version)

    Jun 1, 2012, 00:00

  • UT1 The Impact of Comparative Effectiveness Research on Drug Utilization in the United States

    Jun 1, 2012, 00:00

  • PHP27 Effect of Primary Care Availability and Health Insurance Coverage on Chronic and Acute Preventable Hospitalizations

    Jun 1, 2012, 00:00

  • PMD53 A Review of Health Technology Assessments (HTAS) for Cervical Cancer Screening Technologies

    Jun 1, 2012, 00:00

  • PSY33 Adaptation to Colombia and Venezuela of the Economic Model Dasatinib First-Line Treatment of Chronic Myeloid Leukemia, Developed by the York Health Economics Consortium

    Jun 1, 2012, 00:00

  • PCV24 Congestive Heart Failure Gap Analysis. Population Perspectives from Lake County, IL, USA

    Jun 1, 2012, 00:00

  • PRM32 One Day Money Will Only Be Spent on Effective Drugs…from Payers' Aspirations to Performance-Based Risk-Sharing Operations

    Jun 1, 2012, 00:00

  • PCN5 Cancer During Pregnancy- Clinical and Economic Characteristics Associated With Inpatient Cases in the United States

    Jun 1, 2012, 00:00

  • PDB28 Spending on Medicines and Inputs to Control Diabetes in the State of Minas Gerais. Brazil

    Jun 1, 2012, 00:00

  • PMD34 Cost Effectiveness Model- Comparison of Closed Incision Management Using Negative Pressure and Standard of Care Over Clean Closed Incisions Based on a 2012 Randomized Controlled Trial

    Jun 1, 2012, 00:00

  • PCN123 Retrospective Study of Health Care Utilization and Costs in Women With Metastatic Breast Cancer (MBC) Receiving Lapatinib After Treament With Trastuzumab

    Jun 1, 2012, 00:00

  • PCN4 Effect of Treatment Delays on Late-Stage Prostate Cancer Survival

    Jun 1, 2012, 00:00

  • PMS18 The Direct and Indirect Costs of Long Bone Fractures in a Working Age U.S. Population

    Jun 1, 2012, 00:00

  • PGI25 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I Patients

    Jun 1, 2012, 00:00

  • PDB24 Prevalence and Incidence of Type 2 Diabetes Mellitus- An Analysis Based on 5.4 Million Patients

    Jun 1, 2012, 00:00

  • PSU6 Economic Impact of Using Sugammadex for the Reversal of Deep Neuromuscular Blockade in the Swedish Health Care Setting

    Jun 1, 2012, 00:00

  • PCV33 Study on Hospitalization Costs for Patients with Atrial Fibrillation Related Stroke in China

    Jun 1, 2012, 00:00

  • PIN21 A Review of Economic Studies of Rubella and Rubella Vaccination

    Jun 1, 2012, 00:00

  • PMS6 Treatment Pattern Visualization of Medicare Patients Diagnosed with Rheumatoid Arthritis and Initiating Tumor Necrosis Factor Therapy

    Jun 1, 2012, 00:00

  • PCN109 Progressive Worsening of Patient-Reported Outcomes in Untreated Patients With Myelofibrosis

    Jun 1, 2012, 00:00

  • RM4 A Systematic Review of Costs Associated With Prescription Opioid Risks

    Jun 1, 2012, 00:00

  • PIH70 Is Primary Care Accessible for the Poor in Mongolia?

    Jun 1, 2012, 00:00

  • PRM65 Prevalence-Based Versus Incidence-Based Economic Evaluations for the Assessment of New Health Care Interventions

    Jun 1, 2012, 00:00

  • PDB80 Effect of Diabetes Patient Characteristics on the Willingness-to-Pay for a New Basal Insulin – A Discrete Choice Experiment

    Jun 1, 2012, 00:00

  • PUK12 Examining the Dosing Patterns and Costs of Epoetin Alfa and Darbepoetin Alfa among Hospital Inpatients with Chronic Kidney Disease Not on Dialysis

    Jun 1, 2012, 00:00

  • PSS19 Validation of the Paediatric Hearing Impairment Caregiver Experience (PHICE) Instrument

    Jun 1, 2012, 00:00

  • PMH22 Correlates of Dropout from Community-Based Methadone Maintenance Treatment Program in Indonesia

    Jun 1, 2012, 00:00

  • PCN44 Examining the Cost of Chemotherapy Induced Nausea and Vomiting in Patients Treated for Cancer in a Medicaid Population

    Jun 1, 2012, 00:00

  • PRM12 Comparison of Two Approaches to Costing National Immunization Programs- Central Level Budgeting Versus Detailing Costing Exercises Using a Novel Provac EPI Costing Tool in Bolivia

    Jun 1, 2012, 00:00

  • PIH35 Utilization and Adherence One-Year Post CDHP Implementation

    Jun 1, 2012, 00:00

  • MO1 New Concepts in Discrete Choice Preference Measurement- An Application to Drug Treatment for Juvenile Idiopathic Arthritis

    Jun 1, 2012, 00:00

  • PSS7 Health Care Costs and Utilization for Privately Insured Patients Treated for Non-Infectious Uveitis in the United States

    Jun 1, 2012, 00:00

  • PIH72 Impact of Pharmacist Intervention on the Utilization of Teriparatide in Osteoporosis

    Jun 1, 2012, 00:00

  • PCN121 Evaluation of Aromatase Inhibitor Utilization and Failure in Post-Menopausal Women With Advanced ER+/HER2- Breast Cancer

    Jun 1, 2012, 00:00

  • PRM62 Visual Assessment of Fit of Equations to Predict Time-to-Event Outcomes

    Jun 1, 2012, 00:00

  • PCN89 Economic Evaluation of Erlotinib as Treatment of or Metastasic Cancer of Non-Small Cell Lung Cancer (NSCLC) Prior Chemotherapy in Mexico

    Jun 1, 2012, 00:00

  • PCV38 Venous Thromboembolism- A Refined United States Cost Model with Long Term Attack Rates

    Jun 1, 2012, 00:00

  • PIH56 Measuring Quality of Life in Facial Aesthetic Patients- Field-Testing of a New Modular System (the FACE-Q)

    Jun 1, 2012, 00:00

  • PND22 Pharmacoeconomic Assessment of Natalizumab in the Treatment of Multiple Sclerosis

    Jun 1, 2012, 00:00

  • PSU11 Comparing Robot-Assisted to Conventional Video-Assisted Thoracic Surgical (VATS)Lobectomy and Wedge Resection- Results from a Multi-Hospital (Premier) Database

    Jun 1, 2012, 00:00

  • PHP53 Recent Growth in Employer Health Care Spending by Disease- An Update

    Jun 1, 2012, 00:00

  • PMD6 The Clinical Usefulness of CT Coronary Angiography for the Diagnosis of Ischemic Heart Disease in Patients with Chest Pain

    Jun 1, 2012, 00:00

  • PMH32 Impact of Second Generation Anti-Psychotics in Bipolar Patients and Schizophrenia Patients in Th California Medicaid Program

    Jun 1, 2012, 00:00

  • PGI7 Factors Associated with Breakthrough Symptoms and OTC Use Among Gerd Patients in a Real-World Setting

    Jun 1, 2012, 00:00

  • PDB29 Budget Impact Analysis of Norditropin Versus Three Leading Market Growth Hormone Therapies

    Jun 1, 2012, 00:00

  • PMS27 The Cost-Effectiveness of Denosumab for the Prevention of Osteoporotic Fractures in the Setting of the United States

    Jun 1, 2012, 00:00

  • PIN41 Cost-Effectiveness of Vaccination Against Yellow Fever in Ghana

    Jun 1, 2012, 00:00

  • PIN56 Rehospitalization and Costs Among Patients Treated With Linezolid Versus Vancomycin Following Hospitalization for Pneumonia in the Real-World Setting

    Jun 1, 2012, 00:00

  • PCN155 Patient Benefit-Risk Preferences for Advanced Renal Cell Carcinoma Treatments- Results From a Conjoint Analysis Study

    Jun 1, 2012, 00:00

  • PCN24 Epidemiology of the Non-Hodgkin Lymphoma Colombia 2000-2011

    Jun 1, 2012, 00:00

  • PCV5 Intra-Arterial Thrombolysis Versus Standard Treatment or Intravenous Thrombolysis in Adults with Acute Ischemic Stroke- A Systematic Review and Meta-Analysis

    Jun 1, 2012, 00:00

  • PGI3 Validation of Algorithms to Identify Diverticulitis Through Electronic Medical Records in Kaiser Permanente Southern California (KPSC)

    Jun 1, 2012, 00:00

  • PCV79 Survey of Patients with Atrial Fibrillation on the Use of Warfari and Dabigatran

    Jun 1, 2012, 00:00

  • PMH12 National Trends of Psychotropic Medication Use among Patients Diagnosed with Anxiety Disorders- Results from the Medical Expenditure Panel Survey 2004-2009

    Jun 1, 2012, 00:00

  • PDB56 Evaluating the Short-Term Cost-Effectiveness of Liraglutide Versus Sitagliptin in Patients With Type 2 Diabetes Failing Metformin Monotherapy

    Jun 1, 2012, 00:00

  • PSY57 United States Outpatient and Physician Office Visit Patterns Among Psoriasis Patients Receiving Adalimumab or Etanercept

    Jun 1, 2012, 00:00

  • CV1 Differences in Processes and Outcomes of Care in Elderly Hypertensive Diabetic Patients With and Without Dementia

    Jun 1, 2012, 00:00

  • PSU22 Cost-Effectiveness Analysis of Video-Assisted Thoracic Surgery vs. Open Surgery for Patients with Newly Diagnosed Stage I Non-Small Cell Lung Cancer

    Jun 1, 2012, 00:00

  • PRM42 Patient Preferences for Reminders in Clinical Trials- Improving Both Compliance and Patient Experience

    Jun 1, 2012, 00:00

  • PHP64 The Incidence of Potential Drug-Drug Interactions Originating From the Same Prescriber

    Jun 1, 2012, 00:00

  • PIH41 Evaluating the Perception of General Public Towards the Role of Pharmacist in Health Care System of Pakistan

    Jun 1, 2012, 00:00

  • PND21 Cost-Effectiveness Analysis of Antiepileptic Drugs in the Treatment of Lennox-Gastaut Syndrome

    Jun 1, 2012, 00:00

  • PMD54 Urine Drug Monitoring in the Clinic – Who are We Testing, What are We Testing for, and How Often are We Testing?

    Jun 1, 2012, 00:00

  • PDB43 The Cost of Hypoglycemia in Diabetes- Defining the Severity of the Hypoglycemic Event is Key to Understanding the Economic Burden

    Jun 1, 2012, 00:00

  • PMS25 Economic Evaluation of Pharmacological Thromboprophylaxis in Hip Surgery Patients in Mexico

    Jun 1, 2012, 00:00

  • PSS31 Analysis of the Relationship Betweenpsoriasis Severity and Quality of Life, Work Productivity, and Activity Impairment among Patients with Moderate to Severe Psoriasis Using Structural Equation Modeling

    Jun 1, 2012, 00:00

  • PSS24 Patient-Reported Outcomes in a Dental Practice-Based Research Network-PEARL

    Jun 1, 2012, 00:00

  • PHP17 Nation-Wide Survey of Patients' Attitude Toward Low Price Medicine

    Jun 1, 2012, 00:00

  • PDB100 Health Care Utilization and Cost Patterns Among Diabetes Patients Prior to Initiation With Saxagliptin and Other (Non-Insulin) Antidiabetic Medications in a US Health Plan

    Jun 1, 2012, 00:00

  • PHP65 Factors Influencing Reimbursement Price of New Drugs After Introduction of Positive List System

    Jun 1, 2012, 00:00

  • PCV9 Assessment of Renal Function and Impairment by GFR in Atrial Fibrillation (AFIB) Patients in the Outpatient Setting Utilizing an EMR Database

    Jun 1, 2012, 00:00

  • PMS92 Adaptation and Validation of an Indian Version of the Health Related Quality of Life Scale (IND-HAQ) in Indian Patients with Rheumatoid Arthritis

    Jun 1, 2012, 00:00

  • PSY12 A Budget Impact Analysis of Tapentadol Extended Release (ER) for the Treatment of Moderate to Severe Chronic Pain

    Jun 1, 2012, 00:00

  • PIN29 Cost Effectiveness Analysis of Addition of Telaprevir or Boceprevir to Standard Therapy Versus Standard Therapy Alone for the Treatment of Previously Untreated Chronic Hepatitis-C Virus Genotype 1 Infection

    Jun 1, 2012, 00:00

  • PDB67 Impact of Adherence to Oral Diabetes Medication on Short-Term Disability Costs in an Employer Population

    Jun 1, 2012, 00:00

  • PIN19 Costs of Probable Viral Diarrhea in Children Under Five Years Old in Colombia

    Jun 1, 2012, 00:00

  • PIN23 Cost of Diagnosis and Prevention of Congenital Cytomegalovirus Infection

    Jun 1, 2012, 00:00

  • PMD50 Should Patients Be Allowed to Co-Pay for Devices and Technologies in the Future?

    Jun 1, 2012, 00:00

  • PRS52 The Stability of Additive Treatment Effects in Multiple Treatment Comparison Meta-Analysis- a Simulation Study

    Jun 1, 2012, 00:00

  • PHP99 How to Deal With Decision Uncertainty? The Italian Experience With Managed Entry Agreements

    Jun 1, 2012, 00:00

  • PMS3 Comparative Effectiveness Analysis Using “Real-World” Patient Database to Evaluate the Fractures Rates Comparing Annual Zoledronic Acid Infusion with Oral Bisphosphonates

    Jun 1, 2012, 00:00

  • PND55 Determinants of Prescription Drug Expenditures in Patients With Multiple Sclerosis- An Analysis of Medical Expenditure Panel Survey Data, 2002 - 2009

    Jun 1, 2012, 00:00

  • PSY9 Prevalence of Opioid Abuse and Associated Health Care Resource Utilization and Costs in a Managed Care Population

    Jun 1, 2012, 00:00

  • PSY7 Blood Transfusion Management in Elective Major Orthopaedic Surgery (MOS) in France

    Jun 1, 2012, 00:00

  • PSU35 Cost of Unavailable Surgical Instruments in Australian Hospitals

    Jun 1, 2012, 00:00

  • PRM54 A Conceptual Analysis of When Medical Expenditure Panel Survey (MEPS) Meets Cost of Illness (COI) – Are They a Match?

    Jun 1, 2012, 00:00

  • PIH44 Predictive Factors of Pharmacy Satisfaction Using a National Level Data in South Korea

    Jun 1, 2012, 00:00

  • PR3 Qualitative Assessment of Health-Related Productivity Instruments

    Jun 1, 2012, 00:00

  • Table of Contents

    Jun 1, 2012, 00:00

  • DR2 The Relationship Between Pseudoephedrine Sales and Clandestine Methamphetamine Labs

    Jun 1, 2012, 00:00

  • PSU7 Economic Burden of Obesity and the Impact of Bariatric Surgery on Health Care Costs and Utilization

    Jun 1, 2012, 00:00

  • PCN79 Cost Effectiveness of Human Papillomavirus Vaccination for the Prevention of Cervical Cancer in Urban Regions of China

    Jun 1, 2012, 00:00

  • PCV14 Are Vasodilators of Value in the Care of Patients Hospitalized for Acute Heart Failure?

    Jun 1, 2012, 00:00

  • PHP28 Access to Orphan Oncology Drugs in France Versus the United Kingdom

    Jun 1, 2012, 00:00

  • PCV52 Urapidil in Treatment of Hypertension Urgencies in the Russian Federation- Cost-Effectiveness Analysis

    Jun 1, 2012, 00:00

  • PCN130 Evaluating Outcomes of Specialty Medication Services Through a National Health Plan Specialty Program- A Case of Oral Oncology Medications

    Jun 1, 2012, 00:00

  • PSY6 The Impact on Sleep Quality of Butrans® (Buprenorphine) Transdermal System 5 Mcg/Hour (BTDS 5) and 20 Mcg/Hour (BTDS 20) Dosages in Patients With Moderate-to-Severe Chronic Low Back Pain

    Jun 1, 2012, 00:00

  • PUK18 Cost-Effectiveness of Pharmacologic Treatment of Overactive Bladder

    Jun 1, 2012, 00:00

  • PCN62 Cost-Effectiveness Analysis of First-Line Treatment for Metastatic Renal Cell Carcinoma in Colombia

    Jun 1, 2012, 00:00

  • PCN125 Predictors of Methotrexate Containing Chemotherapy in Women Diagnosed With Early Stage Breast Cancer

    Jun 1, 2012, 00:00

  • PIH52 Electronic Patient Reported Outcomes and Data Tool for Chronic Disease Management (PROCDIM)- Case in Point Prostate Cancer

    Jun 1, 2012, 00:00

  • PDB5 Efficacy and Safety of Liraglutide 1.2Mg and Exenatide 10Mcg Twice Daily in Type 2 Diabetes Mellitus- A Systemtic Review and Meta-Analysis

    Jun 1, 2012, 00:00

  • PMH62 Predominant Negative Symptoms in Schizophrenia

    Jun 1, 2012, 00:00

  • PIN38 Economic Evaluation of Anidulafungin for Candidemia or Invasive Candidiasis Therapy in Korea

    Jun 1, 2012, 00:00

  • PCN105 Patient-Reported Outcomes (PROs) and Tolerability of Therapeutic Agents in Patients With Metastatic Prostate Cancer (MPC)- A Systematic Literature Review

    Jun 1, 2012, 00:00

  • PRS43 Comparisons of Patient Characteristics and Health Care Costs by Quartile among Patients with Allergic Rhinitis

    Jun 1, 2012, 00:00

  • PCN28 Budget Impact Analysis of Everolimus for ER+, HER2- Metastatic Breast Cancer Patients in the United States

    Jun 1, 2012, 00:00

  • PMD46 Doctor Knows Best- The Effect of Yea-Saying Bias on Willingness to Pay in Choice-Format Conjoint-Analysis Studies

    Jun 1, 2012, 00:00

  • PDB12 Comparative Effectiveness Study of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Type 2 Diabetes

    Jun 1, 2012, 00:00

  • PCN134 Effects of Clinical Pharmacist Interventions on Clinical Outcomes in Oncology Patients

    Jun 1, 2012, 00:00

  • PIN58 Hospital Outcomes and Costs of Care for Severe Sepsis- A Population-Based Study

    Jun 1, 2012, 00:00

  • PDB48 Direct Medical Management Costs of Diabetes-Related Complications in Brazil

    Jun 1, 2012, 00:00

  • PND41 Parkinson's Disease Questionnaire (PDQ-39) As a Primary Endpoint in a Trial Comparing Deep Brain Stimulation With Best Medical Therapy Versus Best Medical Therapy Alone for Advanced Parkinson's Disease (PD SURG TRIAL)- A Randomised, O ...

    Jun 1, 2012, 00:00

  • PGI28 Proton Pump Inhibitor (Ppi) Prescribing Patterns, Ppi Costs, and Resource Utilization in a Nationally Representative Sample of Patients with Gastroesophageal Reflux Disease (GERD)

    Jun 1, 2012, 00:00

  • CN3 Multi-Level Modeling of Overall Mortality for Men Diagnosed With Prostate Cancer in Florida

    Jun 1, 2012, 00:00

  • PIH84 Practical Considerations for Estimating Sample Size and Study Duration in Pregnancy Exposure Registries

    Jun 1, 2012, 00:00

  • PND23 Economic Evaluation of Natalizumab Versus Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis in Sweden

    Jun 1, 2012, 00:00

  • PSY66 Use of Medicaid Analytic Extract for Evaluation of Drug Use and Health Services Utilization in Patients With Hemophilia

    Jun 1, 2012, 00:00

  • PRM47 Bayesian Regression Models for Estimation of Illness-Attributable Cost from Aggregate Data

    Jun 1, 2012, 00:00

  • PSU38 Factors Associated with Receiving Primary Hip Arthroplasty Versus No Surgery After Hip Fracture in the United States

    Jun 1, 2012, 00:00

  • PMS31 Cost-Effectiveness Analysis of Golimumab for the Treatment of Rheumatoid Arthritis

    Jun 1, 2012, 00:00

  • PSY24 Association of Patient Cost or Reimbursement Challenges With Health Care Resource Utilization, Quality of Life, and Work Productivity Among Patients With Inflammatory Bowel Disease

    Jun 1, 2012, 00:00

  • PMH24 Differences in Health Care Utilization and Associated Costs Between Patients Prescribed Versus not Prescribed Opioids During an Inpatient or Emergency Department Visit

    Jun 1, 2012, 00:00

  • PND17 Economic Value of Screening for Early Parkinson's Disease

    Jun 1, 2012, 00:00

  • PCN150 Direct Medical Costs of Head and Neck Cancer in the United States- An Analysis Using Pooled Medical Expenditure Panel Survey (MEPS) Data

    Jun 1, 2012, 00:00

  • PHP56 An Analysis of Internal Medication Errors Using Incident Reports at a Teaching Hospital in Japan- A Retrospective Study

    Jun 1, 2012, 00:00

  • PMS46 Patient Trade-Offs Between Frequency and Duration of Biologic Treatments for Rheumatoid Arthritis

    Jun 1, 2012, 00:00

  • PDB97 Treatment Patterns and Outcomes for Patients with Type 2 Diabetes Treated with Oral Fixed Combination or Dual Oral Medications

    Jun 1, 2012, 00:00

  • PDB73 Health Outcomes Among Type 2 Diabetes Patients With Comorbid Obesity in Brazil

    Jun 1, 2012, 00:00

  • PND56 Managed Care and Physician Perceptions of Novel Treatments in Multiple Sclerosis

    Jun 1, 2012, 00:00

  • PHP37 Are Hospital Inpatient Costs Lower for Medicare Advantage Enrollees Than Medicare Fee-for-Service Beneficiaries?

    Jun 1, 2012, 00:00

  • PMH68 Daily Average Consumption and Costs of Duloxetine in Mood and Pain among Commercially Insured Patients in 2011 in the United States

    Jun 1, 2012, 00:00

  • PHP111 Global Evidence Generation - Challenges for the Pharma Industry

    Jun 1, 2012, 00:00

  • IN3 Translating Outcomes from a Dynamic Transmission Model for Varicella Vaccination to Cost-Effectiveness Estimates- The Impact of Different Analytic Approaches on the Results

    Jun 1, 2012, 00:00

  • PSY45 Examining Psoriasis Patient Perspectives of Disease and Treatment- A Novel Multi Discriminate Approach

    Jun 1, 2012, 00:00

  • PCV77 Utilization of Medications for Secondary Prevention of Cardiovascular Morbidity and Mortality in Medicare Beneficiaries

    Jun 1, 2012, 00:00

  • PHP91 Factors Affecting Serum Potassium Measurements After Initiation of Spironolactone at an Academic Medical Center

    Jun 1, 2012, 00:00

  • PCV110 Pharmacoeonomic Evaluation of Secondary Prophylaxis of Acute Coronary Syndrome by Statins in Ukraine

    Jun 1, 2012, 00:00

  • PCN36 Epoetin Alfa and Darbepoetin Alfa Dosing Patterns and Costs in Chemotherapy-Induced Anemia Inpatients

    Jun 1, 2012, 00:00

  • PIN57 Public Expenditure for Antiretroviral Treatment and Projected Cost-Savings After the Entry of Generic Antiretrovirals in the Italian Pharmaceutical Market

    Jun 1, 2012, 00:00

  • PMH74 Pattern of Antidepressants Utilization and Cost in Iran During 2007-2009

    Jun 1, 2012, 00:00

  • PSS18 Comparison of a 24-Hour and 7-Day Version of a Patient Reported Outcome Measure for Psoriasis Symptom Severity

    Jun 1, 2012, 00:00

  • PUK22 Comparison of Utility Score and Quality of Life Score in Thai Patient Between Twice and Thrice-Weekly Hemodialysis

    Jun 1, 2012, 00:00

  • PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases

    Jun 1, 2012, 00:00

  • PDB54 Saxagliptin or Sulfonylurea After Metformin Secondary Failure- a Cost-Effectiveness Analysis in Colombia

    Jun 1, 2012, 00:00

  • PND7 Budget Impact and Cost-Effectiveness of Once-Daily Gabapentin for the Treatment of Postherpetic Neuralgia

    Jun 1, 2012, 00:00

  • PND27 Model of Rasagiline Versus Standard of Care for Parkinson's Disease- Comparison of Progression Effects

    Jun 1, 2012, 00:00

  • PHP54 Health Care Efficiency From Electronic Health Records Implementation- A Preliminary Review of the Literature

    Jun 1, 2012, 00:00

  • PRM40 A Look At Previous and Current Methods Used to Collect Patient-Reported Outcomes Information

    Jun 1, 2012, 00:00

  • PMH54 Using Longitudinal Data to Explain the Impact of Pain on Depression for General Population

    Jun 1, 2012, 00:00

  • PCV50 Cost Effectiveness Analysis of Azilsartan Medoxomil and Chlorthalidone Fixed Dose Combination Therapy for Treatment of Hypertension

    Jun 1, 2012, 00:00

  • PND9 Huntington's Disease (HD) Direct Medical Costs- A Retrospective Claims Database Analysis

    Jun 1, 2012, 00:00

  • PMS76 Two-Year Direct Health Care Cost Burden of Psoriatic Arthritis to Managed Care- A Retrospective Case Study of Golimumab Patients

    Jun 1, 2012, 00:00

  • PMD42 Cost-Effectiveness of Coflex® Interlaminar Stabilization Compared with Instrumented Posterior Spinal Fusion for Spinal Stenosis and Spondylolisthesis

    Jun 1, 2012, 00:00

  • PCN133 Data Linkage for HPV Vaccination, Screening, and Cervical Cancer Outcomes- Is There an Evidence Base for Public Health Decision-Making on Cervical Cancer Prevention Strategies?

    Jun 1, 2012, 00:00

  • PRS4 Burden of Comorbid Depression/Anxiety among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease

    Jun 1, 2012, 00:00

  • PCV55 Cost-Effectivness of Rosuvastatin Versus Ezetimibe/Simvastatin Fixed Combination in Reaching Cholesterol Goals for Mexican Patients

    Jun 1, 2012, 00:00

  • DR1 Public Health Innovation- Biopharmaceuticals Lost in Translation?

    Jun 1, 2012, 00:00

  • PSY41 Evaluating the Frequency and Sequence of Items Administered Using Promis Computer Adaptive Testing

    Jun 1, 2012, 00:00

  • PMH16 Male/Female Incidence Ratio of ADHD Drug Treatment in the Netherlands from 2000 Until 2010

    Jun 1, 2012, 00:00

  • PND47 Rescue Medication Use in the Acute Treatment of Migraine During Map0004 Pivotal Trial

    Jun 1, 2012, 00:00

  • PCN135 Creating Oncology Coverage Policy- The Reliance on Compendia and Treatment Guidelines by 25 Private us Payer

    Jun 1, 2012, 00:00

  • PCN68 Cost-Effectiveness of HER-2-Positive Metastatic-Breast-Cancer Treatment in Post-Herceptin Progression in Colombia

    Jun 1, 2012, 00:00

  • PSU1 Adverse Events Commonly Associated with Opioid Use- Impact Upon Length of Stay Following Surgical Procedure

    Jun 1, 2012, 00:00

  • PRM22 Comparison of Methods for the Evaluation of Ustekinumab Dosing and Costs in Pharmacy Claims Databases

    Jun 1, 2012, 00:00

  • PRM37 A Literature Review of Empirical Studies of Process Utility

    Jun 1, 2012, 00:00

  • PMD49 Do HTA Requirements and Procurement Incentives in Medical Devices Need Re-Aligning?

    Jun 1, 2012, 00:00

  • PHP32 Geographic Variation in Medicare Part D Plan Enrollment, Premiums, Copayment, and Coinsurance

    Jun 1, 2012, 00:00

  • PMH34 Long-Term Cost-Effectiveness of Atypical Antipsychotics for Schizophrenia in the United States

    Jun 1, 2012, 00:00

  • PRM31 Evaluation of Decision Analytic Models in Cost-Effectiveness Analysis in Korea- From Guideline to Practice

    Jun 1, 2012, 00:00

  • PMS59 Burden of Disease in Women with Osteoporosis in Brazil- Results from 2011 National Health and Wellness Survey (NHWS)

    Jun 1, 2012, 00:00

  • PIH28 The Intrinsic Value of Extended-Release Drugs

    Jun 1, 2012, 00:00

  • PIH6 Antipsychotic Use and Risk of Nursing Home Admission among Community-Dwelling Dual Eligible Beneficiaries

    Jun 1, 2012, 00:00

  • PSS3 Using Data Visualization to Illustrate Treatment Patterns of Medicare Patients with Diagnosis of Psoriasis Who Initiated Tumor Necrosis Factor Therapy

    Jun 1, 2012, 00:00

  • PND13 Economic Burden of Lennox-Gastaut Syndrome

    Jun 1, 2012, 00:00

  • PCV32 Health Resource Utilization of Patients with Chronic Thromboembolic Pulmonary Hypertension Versus Pulmonary Aterial Hypertension– Results of a Retrospective Study in Six European Countries

    Jun 1, 2012, 00:00

  • PSY40 Are Neuropathic Pain (NP) Treatment Benefits Reflected in the Self Assessment of Treatment (SAT) Questionnaire?

    Jun 1, 2012, 00:00

  • PDB26 Factors Associated With Three Years of Good or Poor Hemoglobin A1C Control Among Patients With Diabetes

    Jun 1, 2012, 00:00

  • PMD33 Cost-Effectiveness of Molecular IgE in Vitro Diagnostics (IVD) in Children Suspected with Peanut Allergy Compared to Double Blind Placebo Controlled Food Challenge (DBPCFC) in EU, USA and Japan

    Jun 1, 2012, 00:00

  • PMS79 Patient Characteristics and Golimumab Utilization in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Patients

    Jun 1, 2012, 00:00

  • PIN62 Effectiveness of Text Message Reminders for Improving Vaccination Appointment Attendance and Series Completion Among Adolescents and Adults

    Jun 1, 2012, 00:00

  • PHP69 Trends of Emergency Room Visits Versus Hospitalizations Due to Unintentional Poisonings in Kansas City, Missouri

    Jun 1, 2012, 00:00

  • PRM36 International Comparisons of EQ-5D Health-States Valuations

    Jun 1, 2012, 00:00

  • PCV46 Assessing the Cost-Effectiveness of the Recommended Antihypertensive Drug Classes in France Using a Lifetime Markov Model

    Jun 1, 2012, 00:00

  • PRS13 A Budget Impact Analysis of Indacaterol for the Treatment of Chronic Obstructive Pulmonary Disease in Colombia

    Jun 1, 2012, 00:00

  • PIN22 Economic Burden of Hospitalization With Antibiotic Treatment for Absssi in the United States- An Analysis Ofthe Premier Hospital Database

    Jun 1, 2012, 00:00

  • PCN87 Cost-Effectiveness of Hormone Therapies for ER+ Women with Early Breast Cancer in Canada- Exploring the Potential for the Cyp2D6 Genetic Test

    Jun 1, 2012, 00:00

  • PCV37 Burden of Atrial Fibrillation Related Stroke in China

    Jun 1, 2012, 00:00

  • PCV40 Evaluating Health Care Utiliization and Costs Associated with Blood Pressure Control in Patients with Newly Treated Hypertension

    Jun 1, 2012, 00:00

  • PMH18 Factors Associated with Real-World Inpatient Use of Long-Acting Atypical Antipsychotics

    Jun 1, 2012, 00:00

  • PCN147 Evaluating Contemporary Practice in Cml via a Retrospective Research Registry of Patients Across a Comprehensive Cancer Center Database

    Jun 1, 2012, 00:00

  • PHP8 A Review of Economic Evaluations on New Drugs Priced by the Cost Calculation Method in Japan. Can Japan go Beyond the Conventional Cost-Based Pricing?

    Jun 1, 2012, 00:00

  • PMH14 Predictors of Ambulatory Visit Utilization among Patients with Attention Deficit/Hyperactivity Disorder in the United States

    Jun 1, 2012, 00:00

  • PUK17 Economic Benefits of Slowing Progress to End Stage Renal Disease (ESRD) in Patients with Diabetes-Related Chronic Kidney Disease (DKD), Compared with Standard of Care (SOC)

    Jun 1, 2012, 00:00

  • CE2 Comparative Effectiveness of Monotherapy With Mood Stabilizers Versus Atypical Antipsychotics for the Treatment of Bipolar Disorder in Children and Adolescents- A Retrospective Claims-Data Study

    Jun 1, 2012, 00:00

  • MO4 Economic Evaluation of Treatment Strategies for Late-Presentation Acute Ischemic Stroke

    Jun 1, 2012, 00:00

  • PMH84 Validity of Administrative Claims Data for Calculating Adherence Measures for Long-Acting Injectable (Lai) Antipsychotic Therapies

    Jun 1, 2012, 00:00

  • PHP73 Budget Impact Analysis- Do Canadian Guidelines Meet the Needs of Public Drug Plan Managers?

    Jun 1, 2012, 00:00

  • PSS12 Economic Analysis of Etanercept as Continuous or Paused Therapy in Moderate to Severe Psoriasis from a Public Perspective in Venezuela

    Jun 1, 2012, 00:00

  • PCV100 Acute Heart Failure Patients with and Without Renal Impairment- A Study of Heart Failure-Related Resource Utilization and Costs in the United States

    Jun 1, 2012, 00:00

  • PIH32 Demographic and Health Characteristics Associated with Intentional and Unintentional Non-Adherence among Costly Chronic Conditions in the United States

    Jun 1, 2012, 00:00

  • PHP46 Design and Operational Challenges With Time and Motion (TM) Studies Run Alongside Clinical Trials

    Jun 1, 2012, 00:00

  • PCV74 The Relationship Between Hospital Readmission and Post-Discharge Medication Adherence

    Jun 1, 2012, 00:00

  • PDB13 Short Stature in Turner Syndrome- Basal Characteristics and Follow-Up of a Colombian Cohort

    Jun 1, 2012, 00:00

  • PRM60 Operationalising Multiple Criteria Decision Analysis for Health Technology Assessment

    Jun 1, 2012, 00:00

  • PMH45 Utility Scores Associated with the World Health Organisation Drinking Risk-Level Classification in Alcohol Dependence

    Jun 1, 2012, 00:00

  • PIH82 Health Care Screening and Preventive Practices among Women in the United States by Race/Ethnicity

    Jun 1, 2012, 00:00

  • HC4 CMS's Use of Cost-Effectiveness Evidence in NCDs for Prevention

    Jun 1, 2012, 00:00

  • PSY32 Cost- Effectiveness Analysis of Parecoxib in the Management of Postsurgical Pain in Mexico

    Jun 1, 2012, 00:00

  • PGI27 Resource Use and Cost Determinants for Patients with Crohn'S Disease in a Polish Tertiary Hospital

    Jun 1, 2012, 00:00

  • PRS53 Test-Retest Reliability of the Urticaria Patient Daily Diary in Electronic Format among Adults and Adolescents

    Jun 1, 2012, 00:00

  • PCN41 Economic Burden Associated With Adverse Events in Patients With Metastatic Renal Cell Carcinoma

    Jun 1, 2012, 00:00

  • PND30 Health Care Resource Utilization and Quality of Life in Patients With Overactive Bladder Due to Neurogenic Detrusor Overactivity in the United Kingdom- A Database Analysis

    Jun 1, 2012, 00:00

  • PSY29 Lifetime Impact on Bleeding Episodes and Hospitalization of On-Demand Treatment Options in French Hemophilia Patients With Inhibitors

    Jun 1, 2012, 00:00

  • PHP57 An Analysis of Intravenous Medication Errors Using Incident Reports at a Teaching Hospital in Japan

    Jun 1, 2012, 00:00

  • PSS26 Determining Accurate Dosing of Ustekinumab from Specialty Pharmacy Data

    Jun 1, 2012, 00:00

  • PCN132 A NHS Perspective of the Impact of the Cancer Drugs Fund on Oncology Drug Use and Other Health Care Resources Within England

    Jun 1, 2012, 00:00

  • PMS87 Osteoarthritis in France the Cost of Ambulatory Care in 2010

    Jun 1, 2012, 00:00

  • PUK24 Examining the Role of Caregiver Towards Blood Transfusion Decisions among Individuals with Chronic Kidney Disease

    Jun 1, 2012, 00:00

  • PMS69 Tumor Necrosis Factor Blocker Dose Escalation among Biologic Naïve Rheumatoid Arthritis (RA) Patients in Commercial Managed Care Plans in the Two Years Following Therapy Initiation

    Jun 1, 2012, 00:00

  • PCV16 Dynamic Changes and Lifetime Scores for Different Items Measured by WHOQOL-BREF for Patients with Different Types of Ischemic Stroke

    Jun 1, 2012, 00:00

  • PDB70 Health Utility for Patients With Tpye 2 Diabetes Mellitus in China

    Jun 1, 2012, 00:00

  • PMS52 Validation of Remission of Rheumatoid Arthritis by Traditional Disease Activity Score and Provisional Criteria by American College of Rheumatology and European League Agaisnt Rheumatism- Analysis Based on Patient Reported Outcomes fro ...

    Jun 1, 2012, 00:00

  • PHP7 Recent Developments in Pompe Disease Therapy

    Jun 1, 2012, 00:00

  • PMH56 Functioning and Quality of Life in Patients with Bipolar Disorder- Results from the Multinational Longitudinal WAVE-BD Study

    Jun 1, 2012, 00:00

  • PCV88 Evaluating Outcomes Related to Hypertension in Toledo-Lucas County Carenet Patients

    Jun 1, 2012, 00:00

  • HC2 Association of Allergic Rhinitis with Asthma Exacerbations and Health Care Costs in Asthma Patients

    Jun 1, 2012, 00:00

  • PRS45 A Large-Scale Retrospective Study of Emergency Department Visits or Hospitalizations for Anaphylaxis among Patients with Employer- Sponsored Health Insurance

    Jun 1, 2012, 00:00

  • PHP39 The “Weight” of Orphan Drugs in the European Pharmaceutical Policy. A Focus on the Expenditure and the Utilization of Orphan Drugs in Five European Union Countries

    Jun 1, 2012, 00:00

  • PDB30 A Comparison of the Costs for Treating Central Precocious Puberty During the First Year With Leuprolide Acetate Injectible and Histrelin Acetate Implant

    Jun 1, 2012, 00:00

  • PMS15 Cost Analysis of Febuxostat Versus Allopurinol for Prophylaxis of Gout Flares

    Jun 1, 2012, 00:00

  • PCV7 Impact of Comorbidities on Risk of Cardiovascular Hospitalization among Patients with and Without Atrial Fibrillation

    Jun 1, 2012, 00:00

  • PCV56 Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation Under the Private and Public Health Care System in Brazil

    Jun 1, 2012, 00:00

  • PCN60 Cost Effectiveness of Nilotinib, Dasatinib and Imatinib as First Line Treatment of Chronic Myeloid Leukemia in Colombia 2011

    Jun 1, 2012, 00:00

  • PIH59 Patient-Reported Outcomes- The Grounded Item Technique for Generating Content Valid Questions

    Jun 1, 2012, 00:00

  • PDB105 Payor and Prescriber Feasibility Assessment of a Pharmacy Benefit Management (PBM) Diabetes Program Utilizing Pharmacist-Advised Self-Adjusted Basal Insulin

    Jun 1, 2012, 00:00

  • PCN76 Economic Evaluation of the Use of Erlotinib for Non-Small Cell Lung Cancer (NSCLC) With EGFR Mutation in Mexican Public Health Institutions

    Jun 1, 2012, 00:00

  • PSS16 Systematic Review of Cost-Utility Analyses in Age-Related Macular Degeneration

    Jun 1, 2012, 00:00

  • PMH20 Factors Associated with Higher Health Care Resource Use among Patients with Bipolar Disorder- Results from a Large Multinational Longitudinal Study (WAVE-BD)

    Jun 1, 2012, 00:00

  • PIN37 Cost-Effectiveness of Treatment Initiation With Ritonavir-Boosted Atazanavir (ATV/R) and Lopinavir (LPV/R) in Treatment-NaÏve HIV Patients at Different CD4 Levels at Baseline

    Jun 1, 2012, 00:00

  • PCV89 Patient-, Hospital-, and County- Level Predictors of Discharges and Readmissions among Patients with Cardiovascular Disease

    Jun 1, 2012, 00:00

  • CE3 Grace Checklist- Rating the Strength of Evidence for Observational Studies of Comparative Effectiveness

    Jun 1, 2012, 00:00

  • PMD18 Bypass Therapy Assay Testing As a Strategy to Reduce Treatment Costs for Hemophilia Patients with Inhibitors

    Jun 1, 2012, 00:00

  • PCV44 Financial Impact of Bleeding Events on Total Knee and Hip Replacements in the Argentinean Health Care System

    Jun 1, 2012, 00:00

  • PRM50 Meta-Regression Models to Address Heterogeneity and Inconsistency in Network Meta-Analysis of Survival Outcomes

    Jun 1, 2012, 00:00

  • PIH81 A Qualitative Study Evaluating Perceptions of Nurses Towards the Role of Pharmacist in Pakistan

    Jun 1, 2012, 00:00

  • PCV59 Cost-Effectiveness of Dabigatran Etexilate Versus Apirin Plus Clopidogrel Combination in Stroke Prevention in Atrial Fibrillation (SPAF)- Russian Payer Perspective

    Jun 1, 2012, 00:00

  • PSY67 Psychometric Validation of the Pain Impact Questionnaire Revised With a 1-Week Recall

    Jun 1, 2012, 00:00

  • PCV23 Prevalence and Incidence of Atrial Fibrillation- An Analysis Based on 8.3 Million Patients

    Jun 1, 2012, 00:00

  • PMS20 Real Life Treatment Cost of Rheumatoid Arthritis, Psoriasis, Crohn's Disease and Ulcerative Colitis in the Brazilian Private Health Care System

    Jun 1, 2012, 00:00

  • PMH1 Pharmacotherapy and Associated Outcomes in Pediatric Bipolar Depression

    Jun 1, 2012, 00:00

  • ISPOR 17th Annual International Meeting Research Abstracts Author Index

    Jun 1, 2012, 00:00

  • PCN58 A Comprehensive Cost-Effectiveness Analysis of Lenalidomide for Multiple Myeloma Patients who Have Received at Least One Prior Therapy

    Jun 1, 2012, 00:00

  • PMD8 Efficacy of Systemic Hyperbaric Oxygen Therapy for Non-Healing Diabetic Ulcers of the Lower Limb- Systematic Review and Meta-Analysis

    Jun 1, 2012, 00:00

  • PMS21 Mapping Health Care Costs to Clinical Disease Activity Where Cost Data is Lacking – A Novel Approach Using Medical Expenditure Panel Survey Data with the Corrona Rheumatoid Arthritis Disease Registry

    Jun 1, 2012, 00:00

  • PCV92 Drug Approval Strategies in Germany

    Jun 1, 2012, 00:00

  • PIN17 Cost of Treatment Failure Among Adult Outpatients With Moderate or Complicated Community-Acquired Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Skin Infections- A Starnet Study

    Jun 1, 2012, 00:00

  • PDB86 Evaluation of Pharmacists Time and Therapy Management for Patients With Type 2 Diabetes Served by a Rural Free Clinic

    Jun 1, 2012, 00:00

  • PSY30 Cost Utility Analysis of the Profilaxis Versus On-Demand Treatment With Recombinant Factor IX for the Treatment of Hemophilia B in Mexico

    Jun 1, 2012, 00:00

  • PSU39 Identification of Bariatric Surgical Procedures, Comorbidities and Adverse Events in Payor Data

    Jun 1, 2012, 00:00

  • PCV93 Market Response to Food and Drug Administration'S Safety Warnings- A Case Study Using an Interrupted Time Series Analysis of the Medicare Database for 2006-2008

    Jun 1, 2012, 00:00

  • PSY8 Application of Data Visualization Tool- Treatment Patterns of Medicare Patients With Ankylosing Spondylitis who Initiated Tumor Necrosis Factor Therapy

    Jun 1, 2012, 00:00

  • PMS19 Impact of Disease Severity on the Total, Health-Related, Financial Costs of Treatment of People with Rheumatoid Arthritis in the United Kingdom

    Jun 1, 2012, 00:00

  • PUK8 Nocturia and the Risk of Falls, Fractures, and Sleep Disturban a Systematic Review and Meta-Analysis

    Jun 1, 2012, 00:00

  • PDB72 The Impact on Utilities of Weight Loss and Weight Gain Among Canadian Patients With Type 2 Diabetes

    Jun 1, 2012, 00:00

  • PMH46 Examining the Differences Between Patients Treated for Major Depressive Disorder Compared to Those Who do not Realize They Have Major Depressive Disorder

    Jun 1, 2012, 00:00

  • PMD13 Assessing the Budget Impact of Using ScanBag® in CT in Six European Countries

    Jun 1, 2012, 00:00

  • PRM20 Comparing the Use of Secondary Data Sources in Two Types of Journals During 2010

    Jun 1, 2012, 00:00

  • PMH5 Association Between Second Generation Antipsychotics and Changes in Body Mass Index in Adolescents

    Jun 1, 2012, 00:00

  • PMH26 Modeling Economic Consequences of Cardiometabolic Changes with Lurasidone Versus Other Atypical Antipsychotics in Schizophrenia

    Jun 1, 2012, 00:00

  • PRS40 Measurement of Primary Medication Adherence among Children with Asthma Using Administrative Claims Data

    Jun 1, 2012, 00:00

  • MO2 The Cost-Effectiveness of Primary Stroke Centers for Acute Stroke Care

    Jun 1, 2012, 00:00

  • UT3 Firm- and Drug-Specific Patterns of Generic Drug Prices Experienced by United States Medicaid Programs- 1991-2008

    Jun 1, 2012, 00:00

  • PMS28 Economic Evaluation of the Use of Anti TNF's and Tocilizumab for the Treatment of Systemic Juvenile Idiopathic Arthritis (sJIA) in Mexico

    Jun 1, 2012, 00:00

  • PDB7 Efficacy and Safety of Liraglutide 1.2Mg Once Daily in Type 2 Diabetes Mellitus- A Systematic Review and Meta-Analysis

    Jun 1, 2012, 00:00

  • PDB76 Gap Analysis of Existing Diabetes-Specific Health-Related Quality of Life Measures for Use Among Multi-Ethnic English-Speaking Asians With Diabetes- An Interim Analysis

    Jun 1, 2012, 00:00

  • PDB83 Diabetes Medication Usage Patterns in Geographies With High Hispanic Populations in the United States

    Jun 1, 2012, 00:00

  • PDB88 Impact of Telephone and Mail Intervention on Diabetes Appointment Adherence Rates and Clinical Outcomes

    Jun 1, 2012, 00:00

  • PDB111 Accounting for Psychological Determinants of Treatment Response in Health Economic Simulation Models of Behavioural Interventions- A Case Study in Type 1 Diabetes

    Jun 1, 2012, 00:00

  • PCV41 Analysis of Direct Costs Associated with INR Monitoring and Warfarin Dose Ajustment in Patients with Atrial Fibrillation

    Jun 1, 2012, 00:00

  • PIN15 Impact of Surgical Staphylococcus Aureus Infections on US Hospitals

    Jun 1, 2012, 00:00

  • PCN128 Predictors of Non-Participation in a Surveillance Study of Appalachian Women Participating in a State-Wide Mobile Mammography Program

    Jun 1, 2012, 00:00

  • PMD15 The Economic Burden of Atrial Fibrillation among Elderly Populations in Selected Developed Countries

    Jun 1, 2012, 00:00

  • PCN25 Effect of Treatments for Late-Stage Prostate Cancer on Survival

    Jun 1, 2012, 00:00

  • PRM56 Modeling the Progression of Chronic Diseases in a Dynamic Market- Implications for Budget Impact Analysis

    Jun 1, 2012, 00:00

  • IN1 Antibiotic Prescribing via Telephone- How Often Does it Occur?

    Jun 1, 2012, 00:00

  • PSY27 Cost Effectiveness of Treatment With Etanercept or Ustekinumab for Moderate to Severe Psoriasis

    Jun 1, 2012, 00:00

  • PDB25 Impact of Diabetes in Patients Hospitalized for Pneumonia

    Jun 1, 2012, 00:00

  • PIH83 Health Technology Assessment in Child Health

    Jun 1, 2012, 00:00

  • PCN72 Cost Effectiveness Analysis of New Treatments for Metastatic Castration-Resistant Prostate Cancer- Does Severity Matter?

    Jun 1, 2012, 00:00

  • PMS26 Cost-Effectiveness of Denosumab Versus Oral Bisphosphonates in the United States for Post-Menopausal Osteoporosis (PMO)

    Jun 1, 2012, 00:00

  • PDB19 A Comparison of Standards of Diabetes Care Across Different Racial/Ethnic Groups in the United States Non-Institutionalized Adult Population- A Study Using the 2009-2010 Nhanes Cohort

    Jun 1, 2012, 00:00

  • PRM2 Network Meta-Analysis of Individual and Aggregate Level Data

    Jun 1, 2012, 00:00

  • PMD32 Cost-Effectiveness of Drug-Eluting Stents Versus Bare-Metal Stents for Single- and Multi-Vessel Percutaneous Coronary Intervention

    Jun 1, 2012, 00:00

  • PHP105 A Review of Different Approaches Proposed for Value Based Pricing

    Jun 1, 2012, 00:00

  • PMD44 Assessing Performance Following Primary Total Knee Arthroplasty (TKA)- Development of the Patient'S Knee Implant Performance (PKIP) Measure

    Jun 1, 2012, 00:00

  • PCN15 A Longitudinal Review of Treatment Patterns in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) From Community Practice in the United States

    Jun 1, 2012, 00:00

  • PRM52 Systematic Review of Guideline Recommendations on Comparator Selection in Health Economic Evaluations

    Jun 1, 2012, 00:00

  • SB4 Propensity-Score Matching (PSM) to Control for Selection Bias in “Real-World” Treatment Comparisons- A Cautionary Tale Concerning Antibiotic Therapy for Infectious Disease

    Jun 1, 2012, 00:00

  • PHP106 Priority Setting for Health Technology Assessment in Ukraine

    Jun 1, 2012, 00:00

  • PMD22 Comparative Cost Between Vertebroplasty and Kyphoplasty for the Treatment of Vertebral Compression Fractures

    Jun 1, 2012, 00:00

  • PCV27 Survival to Discharge After Cardiac Arrest in a Pediatric Population- Results from the Kids' Inpatient Database, 2003-2009 in the United States

    Jun 1, 2012, 00:00

  • PCV22 Treatment Patterns and Outcomes in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension- Results of a Retrospective Chart Review in Six European Countries

    Jun 1, 2012, 00:00

  • PMD51 National Trends in Advanced Diagnostic Imaging Use in Outpatient Settings- an Analysis of the Medical Expenditure Panel Survey, 2000-2009

    Jun 1, 2012, 00:00

  • ISPOR 17th Annual International Meeting Financial Disclosure Information for Research Presentations

    Jun 1, 2012, 00:00

  • PIH11 Prevalence and Incidence Rates of Most Common Comorbid Conditions among Patients with Tuberous Sclerosis Complex- A Naitonal Claim Database Analysis

    Jun 1, 2012, 00:00

  • PCV83 Preliminary Assessment of the Utility of Short Performance Physical Battery (SPPB) and Ferrans and Power'S Quality of Life Questionnaire (QLI) in Advanced Heart Failure Patients

    Jun 1, 2012, 00:00

  • PDB96 Racial Variations in the Use of Thiazolidinediones in a Medicaid Population

    Jun 1, 2012, 00:00

  • PSY47 Pharmacists' Beliefs Regarding Intention to Utilize Prescription Drug Monitoring Program (PDMP) Data

    Jun 1, 2012, 00:00

  • PCN92 The Lifecycle Value of Oncology Medicines

    Jun 1, 2012, 00:00

  • PHP25 Deriving Patient Chronic Disease Conditions From Medication Utilization Using Combination of Clinical Rules and Logistic Regression

    Jun 1, 2012, 00:00

  • PIH15 Application of Probabilistic Linkage- Compare Health Care Costs among Menopausal Women with Different Symptoms by Linking Women's Registry and Claims Database

    Jun 1, 2012, 00:00

  • PDB40 Economic Burden of Type 2 Diabetes Mellitus in China

    Jun 1, 2012, 00:00

  • PMH79 Medical Costs and Hospitalizations among Persons with Depression Treated with Adjunctive Atypical Antipsychotic Therapy

    Jun 1, 2012, 00:00

  • PDB16 Treated to Glycemic Control Target Assessed by Fasting Plasma Glucose (Fpg) and Glycated Hemoglobin (Hba1C) in Patients With Type II Diabetes

    Jun 1, 2012, 00:00

  • PDB39 The Cost of Complications Associated With Diabetes- A Retrospective Claims Database Study

    Jun 1, 2012, 00:00

  • PMH38 Cost-Effectiveness of Asenapine in the Treatment of Schizophrenia in Canada

    Jun 1, 2012, 00:00

  • PCN75 Economic Evaluation of Bevacizumab for the Treatment of Advanced Ovarian Cancer in Mexico

    Jun 1, 2012, 00:00

  • PCN23 Incidence of Metastatic Hormone Receptor Positive (HR+) Breast Cancer in the United Kingdom (UK)- Data Needed!

    Jun 1, 2012, 00:00

  • PHP14 Federal Actions Involving Health Care Fraud and Abuse (2006-2010)

    Jun 1, 2012, 00:00

  • PMS17 Cost Minimization of Anti-TNF Biologics in the Treatment of Rheumatoid Arthritis, Akylosing Spondylitis and Psoriatic Arthritis in the Brazilian Public Health Care System

    Jun 1, 2012, 00:00

  • PMH64 Anti-Anxiety Medication Utilization among Patients with Anxiety Disorder- Analysis of Medical Expenditure Panel Survey

    Jun 1, 2012, 00:00

  • PMS85 Why the Findings of Published Rheumatoid Arthritis Multiple Treatment Comparisons are So Different - An Overview of Recurrent Methodological Shortcomings

    Jun 1, 2012, 00:00

  • PDB84 Liberalization of Medical Savings Accounts for Outpatient Treatment and Health Care Utilization Among Type 2 Diabetes Mellitus Patients

    Jun 1, 2012, 00:00

  • PSU37 National Inpatient Burden Associated with Spinal Cord Injuries in the United States

    Jun 1, 2012, 00:00

  • PIN14 Resource Utilization and Costs of Treating Complicated Skin and Skin Structure Infections With Daptomycin or Telavancin

    Jun 1, 2012, 00:00

  • PIN33 Pharmacoeconomic Evaluation of 13-Valent Pneumococcal Conjugate and 23-Valent Pneumococcal Polysaccharide Vaccine in Canadian Adults

    Jun 1, 2012, 00:00

  • PCV64 Health Care Resource Utilization and Costs for Acromegaly- A Retrospective Study in a Large Claims Database in the United States

    Jun 1, 2012, 00:00

  • PSS14 Economic Analysis of Etanercept as Paused Therapy in Moderate to Severe Psoriasis from a Public Perspective in Brazil

    Jun 1, 2012, 00:00

  • PRS22 Cost-Effectiveness of Indacaterol on Patients with Chronic Obstructive Pulmonary Disease (Copd) at the Public Mexican Health Care System

    Jun 1, 2012, 00:00

  • PUK21 Cost-Effectiveness Analysis of Solifenacin Succinate Versus Trospium Chloride in the Treatment of Patients with Overactive Bladder in Germany

    Jun 1, 2012, 00:00

  • PRS23 Economic Analysis of Vorizonazole, Amphotericine B and Caspofungin for Invasive Aspergilosis Patients in Private Hospitals in Dominican Republic

    Jun 1, 2012, 00:00

  • PMH23 Impact of Refill and Save Program on Adherence to Desvenlafaxine and Extended Release Venlafaxine HCl

    Jun 1, 2012, 00:00

  • PMH76 Impact of Fda Black Box Warning on the Prescribing of Atypical Antipsychotics in Non-Institutionalized Dementia Patients

    Jun 1, 2012, 00:00

  • PRS48 The Trends of Child Obesity and the Effect of Child Obesity on Asthma in Young Children

    Jun 1, 2012, 00:00

  • PMD36 The Use of Chlorhexidine Gluconate Impregnated Sponge Dressings to Prevent Central-Line Associated Bloodstream Infections and Local Site Infections in Canadian Hospitals- An Economic Analysis

    Jun 1, 2012, 00:00

  • PSY65 Meta-Analysis of Health-Related Quality of Life Outcomes – Methods for Enhancing Interpretability of Findings

    Jun 1, 2012, 00:00

  • PSY49 Smoking Cessation Medication Use Among Adult Smokers With Various Body Weight Levels – an NHANES Study

    Jun 1, 2012, 00:00

  • PND35 Fictitious Preferences or Felicitous Recoding? Conjoint Respondents Who Make Sense of Nonsensical Questions

    Jun 1, 2012, 00:00

  • PCV94 Unpacking the Rapid Grwoth of Pharmaceutical Spending Growth- A Case Analysis of Chinese Hospital

    Jun 1, 2012, 00:00

  • PRS47 Predictors of Willingness to Quit among a Cohort of Adult Smokers in India

    Jun 1, 2012, 00:00

  • PMD45 Variation in Health Related Quality of Life Improvement After Percutaneous Coronary Intervention

    Jun 1, 2012, 00:00

  • PCV18 Evaluation of Response to Loading Doses of Clopidogrel Therapy in Patients Undergoing Percutaneous Coronary Intervention (PCI)

    Jun 1, 2012, 00:00

  • PIH1 The Clinical Consequences of Exposure to Clinically Important Drug-Drug Interactions

    Jun 1, 2012, 00:00

  • Copyright/Subscription

    May 1, 2012, 00:00

  • Agreement between Internet-Based Self- and Proxy-Reported Health Care Resource Utilization and Administrative Health Care Claims

    May 1, 2012, 00:00

  • Cost-Effectiveness of Aldosterone Antagonists for the Treatment of Post–Myocardial Infarction Heart Failure

    May 1, 2012, 00:00

  • The EUROHIS-QOL 8-Item Index- Comparative Psychometric Properties to Its Parent WHOQOL-BREF

    May 1, 2012, 00:00

  • QALY Weights for Diabetic Retinopathy—A Comparison of Health State Valuations with HUI-3, EQ-5D, EQ-VAS, and TTO

    May 1, 2012, 00:00

  • Simulated Value-Based Insurance Design Applied to Statin Use by Medicare Beneficiaries with Diabetes

    May 1, 2012, 00:00

  • Guidelines for Health Technologies- Specific Guidance for Oncology Products in Canada

    May 1, 2012, 00:00

  • On Discounting of Health Gains from Human Papillomavirus Vaccination- Effects of Different Approaches

    May 1, 2012, 00:00

  • Comment on the Use of Vignettes and the EQ-5D to Value Disease-Specific Health States

    May 1, 2012, 00:00

  • Mapping the Functional Assessment of Cancer Therapy-General or -Colorectal to SF-6D in Chinese Patients with Colorectal Neoplasm

    May 1, 2012, 00:00

  • Beyond the FDA PRO Guidan Steps toward Integrating Meaningful Patient-Reported Outcomes into Regulatory Trials and US Drug Labels

    May 1, 2012, 00:00

  • Efficacy of Once-Daily Indacaterol Relative to Alternative Bronchodilators in COPD- A Patient-Level Mixed Treatment Comparison

    May 1, 2012, 00:00

  • Comparison of 7-Day Recall and Daily Diary Reports of COPD Symptoms and Impacts

    May 1, 2012, 00:00

  • Handling Input Correlations in Pharmacoeconomic Models

    May 1, 2012, 00:00

  • Coverage with Evidence Development, Only in Research, Risk Sharing, or Patient Access Scheme? A Framework for Coverage Decisions

    May 1, 2012, 00:00

  • Reflections- NICE, Health Economics, and Outcomes Research

    May 1, 2012, 00:00

  • A Review of Patient-Reported Outcome Labels in the United States- 2006 to 2010

    May 1, 2012, 00:00

  • Breast and Prostate Cancer Productivity Costs- A Comparison of the Human Capital Approach and the Friction Cost Approach

    May 1, 2012, 00:00

  • Table of Contents

    May 1, 2012, 00:00

  • Tails from the Peak District- Adjusted Limited Dependent Variable Mixture Models of EQ-5D Questionnaire Health State Utility Values

    May 1, 2012, 00:00

  • Instructions for Authors

    May 1, 2012, 00:00

  • Mapping from Disease-Specific Measures to Health-State Utility Values in Individuals with Migraine

    May 1, 2012, 00:00

  • Editorial Board

    May 1, 2012, 00:00

  • Decision-Making Criteria among National Policymakers in Five Countries- A Discrete Choice Experiment Eliciting Relative Preferences for Equity and Efficiency

    May 1, 2012, 00:00

  • Australian Managed Entry Scheme- A New Manageable Process for the Reimbursement of New Medicines?

    May 1, 2012, 00:00

  • Do General Practitioners Know Patients' Preferences? An Empirical Study on the Agency Relationship at an Aggregate Level Using a Discrete Choice Experiment

    May 1, 2012, 00:00

  • A Reply to Comment on the Use of Vignettes and the EQ-5D to Value Disease-Specific Health States

    May 1, 2012, 00:00

  • Reasons for Rejection of Patient-Reported Outcome Label Claims- A Compilation Based on a Review of Patient-Reported Outcome Use among New Molecular Entities and Biologic License Applications, 2006–2010

    May 1, 2012, 00:00

  • Condition-Specific Preference-Based Measures- Benefit or Burden?

    May 1, 2012, 00:00

  • Exploring the Relationship between Alzheimer's Disease Severity and Longitudinal Costs

    May 1, 2012, 00:00

  • Guide for Authors

    Mar 1, 2012, 00:00

  • Cost-Effectiveness Analysis of Collaborative Care Management of Major Depression among Low-Income, Predominantly Hispanics with Diabetes

    Mar 1, 2012, 00:00
  • «
  • 121
  • 122
  • 123
  • 124
  • 125 (current)
  • 126
  • 127
  • 128
  • 129
  • 130
  • »